Literature DB >> 25981364

Rivaroxaban-induced liver injury: Results from a venous thromboembolism registry.

Aude Lambert1, Mihaela Cordeanu2, Sébastien Gaertner2, Salah Nouri2, Martine Alt1, Dominique Stephan3.   

Abstract

Entities:  

Keywords:  Drug-induced liver injury; Rivaroxaban; Venous thromboembolism

Mesh：

Substances：

Year:  2015        PMID： 25981364     DOI： 10.1016/j.ijcard.2015.04.248

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

1.  Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.

Authors:  Luca Monaco; Chiara Biagi; Valentino Conti; Mauro Melis; Monia Donati; Mauro Venegoni; Alberto Vaccheri; Domenico Motola
Journal:  Br J Clin Pharmacol       Date:  2017-03-19       Impact factor: 4.335

Review 2.  Hepatotoxicity of New Oral Anticoagulants (NOACs).

Authors:  Evangelia Liakoni; Alexandra E Rätz Bravo; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2015-08       Impact factor: 5.606

3.  Drug induced hepatitis mimicking Wilson's disease secondary to the use of complex naturopathic regimens: a case report.

Authors:  Tyler Pitre; Jasmine Mah; Jaclyn Vertes; Rosario Rebello; Julie Zhu
Journal:  BMC Gastroenterol       Date:  2019-11-27       Impact factor: 3.067

4.  Non-hemorrhage-related adverse effects of rivaroxaban.

Authors:  Eliza C Christopoulou; Theodosios D Filippatos; Moses S Elisaf
Journal:  Arch Med Sci Atheroscler Dis       Date:  2017-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.